The year in gout - 2010-2011.
Over the past decade, the pace of investigation in the field  of gout has accelerated tremendously. New advances have  led to deeper insight into the processes of inflammation and  innate immunity, and new treatments are now available, or  likely to become available in the near future. Some of the  more interesting new findings in the field of gout are presented in the context of gout biology and treatment overall.  Gout epidemiology, current understanding of renal urate  handling, recent investigations into the mechanism of inflammation in acute gout, dietary factors in gout development,  the potential role of hyperuricemia in cardiovascular and  renal disease, and treatments that are either newly available  or in development are discussed.
Rheumatology Section, New York Harbor VA Healthcare System New York Campus, New York, New York, USA.
Daria B
DB
Crittenden
Michael H
MH
Pillinger
D006073:Gout / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology / Q000503:physiopathology; D006074:Gout Suppressants / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D033461:Hyperuricemia / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology / Q000503:physiopathology; D016896:Treatment Outcome
D006074:Gout Suppressants